Financials

  • Market Capitalization 108.71 M
  • Employee 152
  • Founded 2013
  • CEO N/A
  • Website www.lenz-tx.com
  • Headquarter Delaware, United States
  • FIGI BBG00XDH4NZ2
  • Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-5.61
ratio cours/chiffre d'affaires
24.15

Related tickers

#NomPrix24h %7 jours %1M %1 an %Cap Boursière7 Derniers Jours
3817
TNXP
Tonix Pharmaceuticals Holding Corp. - Common Stock
6.42 USD-3.31%-20.74%-45.50%-57.23%110.11 M USD
3818
UNCY
Unicycive Therapeutics, Inc. - Common Stock
3.80 USD-6.17%-10.38%-27.89%-41.63%105.85 M USD
3826
COYA
Coya Therapeutics, Inc. - Common Stock
4.60 USD-4.37%-7.63%+4.78%-22.30%107.91 M USD
3827
CBUS
Cibus, Inc. - Class A Common Stock
1.41 USD-4.73%-12.42%-10.19%-3.42%107.76 M USD